PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-26.98%
Negative net income growth while VUZI stands at 11.25%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
9.09%
Less D&A growth vs. VUZI's 22.92%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-66.67%
Negative yoy deferred tax while VUZI stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-14.29%
Both cut yoy SBC, with VUZI at -72.80%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-125.44%
Both reduce yoy usage, with VUZI at -19.64%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-99.44%
Both yoy AR lines negative, with VUZI at -73.35%. Martin Whitman would suspect an overall sector lean approach or softer demand.
178.79%
Inventory growth well above VUZI's 80.56%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-36.23%
Both negative yoy AP, with VUZI at -192.98%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-8.33%
Negative yoy usage while VUZI is 352.14%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
100.00%
Well above VUZI's 100.00%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-72.15%
Both yoy CFO lines are negative, with VUZI at -38.64%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
20.45%
Some CapEx rise while VUZI is negative at -18.60%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-47.09%
Negative yoy purchasing while VUZI stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-57.46%
We reduce yoy sales while VUZI is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-107.69%
We reduce yoy other investing while VUZI is 6.90%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-623.38%
Both yoy lines negative, with VUZI at -13.57%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
137.50%
Stock issuance far above VUZI's 124.06%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
No Data
No Data available this quarter, please select a different quarter.